,title,source,link,date
23,These 45 smallcap stocks gain 15-40% as Sensex logs second weekly gain led by global cues; do you own? | Mint,Mint,news.google.com/articles/CBMiqwFodHRwczovL3d3dy5saXZlbWludC5jb20vbWFya2V0L3N0b2NrLW1hcmtldC1uZXdzL3RoZXNlLTQ1LXNtYWxsY2FwLXN0b2Nrcy1nYWluZWQtMTUtNDAtYXMtc2Vuc2V4LWxvZ3Mtc2Vjb25kLXdlZWtseS1nYWluLWxlZC1ieS1nbG9iYWwtY3Vlcy1kby15b3Utb3duLTExNjk5NzExNzgxMTE1Lmh0bWzSAa8BaHR0cHM6Ly93d3cubGl2ZW1pbnQuY29tL21hcmtldC9zdG9jay1tYXJrZXQtbmV3cy90aGVzZS00NS1zbWFsbGNhcC1zdG9ja3MtZ2FpbmVkLTE1LTQwLWFzLXNlbnNleC1sb2dzLXNlY29uZC13ZWVrbHktZ2Fpbi1sZWQtYnktZ2xvYmFsLWN1ZXMtZG8teW91LW93bi9hbXAtMTE2OTk3MTE3ODExMTUuaHRtbA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-11
1,"Lupin, Amman Pharma collaborates for exclusive marketing of Ranibizumab",Business Standard,news.google.com/articles/CBMiiwFodHRwczovL3d3dy5idXNpbmVzcy1zdGFuZGFyZC5jb20vY29tcGFuaWVzL25ld3MvbHVwaW4tYW1tYW4tcGhhcm1hLWNvbGxhYm9yYXRlcy1mb3ItZXhjbHVzaXZlLW1hcmtldGluZy1vZi1yYW5pYml6dW1hYi0xMjMxMTEwMDA1MTFfMS5odG1s0gGPAWh0dHBzOi8vd3d3LmJ1c2luZXNzLXN0YW5kYXJkLmNvbS9hbXAvY29tcGFuaWVzL25ld3MvbHVwaW4tYW1tYW4tcGhhcm1hLWNvbGxhYm9yYXRlcy1mb3ItZXhjbHVzaXZlLW1hcmtldGluZy1vZi1yYW5pYml6dW1hYi0xMjMxMTEwMDA1MTFfMS5odG1s?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
37,Balsalazide Industry is Booming Globally by 2030 | Salix ...,Argyle Report,news.google.com/articles/CBMiigFodHRwczovL3d3dy5hcmd5bGVyZXBvcnQuY29tL25ld3MvYmFsc2FsYXppZGUtaW5kdXN0cnktaXMtYm9vbWluZy1nbG9iYWxseS1ieS0yMDMwLXNhbGl4LXBoYXJtYWNldXRpY2Fsc2JhdXNjaC1oZWFsdGgtYW50ZXItYXBvdGV4LzM2NjgwNS_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
0,Lupin and Amman Pharma Sign Exclusive Licensing and Supply ...,Lupin,news.google.com/articles/CBMidmh0dHBzOi8vd3d3Lmx1cGluLmNvbS9sdXBpbi1hbmQtYW1tYW4tcGhhcm1hLXNpZ24tZXhjbHVzaXZlLWxpY2Vuc2luZy1hbmQtc3VwcGx5LWFncmVlbWVudC1mb3ItcmFuaWJpenVtYWItYmlvc2ltaWxhci_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
2,Lupin and Amman Pharma sign licensing agreement for Ranibizumab biosimilar,Moneycontrol,news.google.com/articles/CBMiigFodHRwczovL3d3dy5tb25leWNvbnRyb2wuY29tL25ld3MvYnVzaW5lc3Mvc3RvY2tzL2x1cGluLWFuZC1hbW1hbi1waGFybWEtc2lnbi1saWNlbnNpbmctYWdyZWVtZW50LWZvci1yYW5pYml6dW1hYi1iaW9zaW1pbGFyLTExNzE3NjIxLmh0bWzSAY4BaHR0cHM6Ly93d3cubW9uZXljb250cm9sLmNvbS9uZXdzL2J1c2luZXNzL3N0b2Nrcy9sdXBpbi1hbmQtYW1tYW4tcGhhcm1hLXNpZ24tbGljZW5zaW5nLWFncmVlbWVudC1mb3ItcmFuaWJpenVtYWItYmlvc2ltaWxhci0xMTcxNzYyMS5odG1sL2FtcA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
81,Culprits: Is Gemma Arterton's Lupin-style show worth watching?,Digital Spy,news.google.com/articles/CBMiR2h0dHBzOi8vd3d3LmRpZ2l0YWxzcHkuY29tL3R2L2E0NTc2NTIzNS9jdWxwcml0cy1nZW1tYS1hcnRlcnRvbi1yZXZpZXcv0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-09
70,"Active Pharmaceutical Ingredients CDMO Market worth $229.39 billion by 2030, growing at a CAGR of 10.32% - Exc",openPR,news.google.com/articles/CBMiXmh0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMjgyMTg0L2FjdGl2ZS1waGFybWFjZXV0aWNhbC1pbmdyZWRpZW50cy1jZG1vLW1hcmtldC13b3J0aC0yMjktMznSAV1odHRwczovL3d3dy5vcGVucHIuY29tL2FtcC8zMjgyMTg0L2FjdGl2ZS1waGFybWFjZXV0aWNhbC1pbmdyZWRpZW50cy1jZG1vLW1hcmtldC13b3J0aC0yMjktMzk?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-09
14,"Stocks to Watch: Power Finance, Tata Power, Lupin, Raymond, HAL, Bata India | Mint",Mint,news.google.com/articles/CBMiiwFodHRwczovL3d3dy5saXZlbWludC5jb20vbWFya2V0L3N0b2NrLW1hcmtldC1uZXdzL3N0b2Nrcy10by13YXRjaC1wb3dlci1maW5hbmNlLXRhdGEtcG93ZXItbHVwaW4tcmF5bW9uZC1oYWwtYmF0YS1pbmRpYS0xMTY5OTQ5MTk3NTI5Mi5odG1s0gGPAWh0dHBzOi8vd3d3LmxpdmVtaW50LmNvbS9tYXJrZXQvc3RvY2stbWFya2V0LW5ld3Mvc3RvY2tzLXRvLXdhdGNoLXBvd2VyLWZpbmFuY2UtdGF0YS1wb3dlci1sdXBpbi1yYXltb25kLWhhbC1iYXRhLWluZGlhL2FtcC0xMTY5OTQ5MTk3NTI5Mi5odG1s?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-09
4,"Lupin Q2 results preview: Strong earnings growth to be led by new launches in the US, improving domestic sales | Mint",Mint,news.google.com/articles/CBMiqgFodHRwczovL3d3dy5saXZlbWludC5jb20vbWFya2V0L3N0b2NrLW1hcmtldC1uZXdzL2x1cGluLXEyLXByZXZpZXctc3Ryb25nLWVhcm5pbmdzLWdyb3d0aC10by1iZS1sZWQtYnktbmV3LWxhdW5jaGVzLWluLXRoZS11cy1pbXByb3ZpbmctZG9tZXN0aWMtc2FsZXMtMTE2OTk0Mjk1OTU0NTQuaHRtbNIBrgFodHRwczovL3d3dy5saXZlbWludC5jb20vbWFya2V0L3N0b2NrLW1hcmtldC1uZXdzL2x1cGluLXEyLXByZXZpZXctc3Ryb25nLWVhcm5pbmdzLWdyb3d0aC10by1iZS1sZWQtYnktbmV3LWxhdW5jaGVzLWluLXRoZS11cy1pbXByb3ZpbmctZG9tZXN0aWMtc2FsZXMvYW1wLTExNjk5NDI5NTk1NDU0Lmh0bWw?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-08
3,Lupin Q2 FY2024 Results,Lupin,news.google.com/articles/CBMiLmh0dHBzOi8vd3d3Lmx1cGluLmNvbS9sdXBpbi1xMi1meTIwMjQtcmVzdWx0cy_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-08
